Pro Publica, Inc. and Charles Ornstein, Hearst Newspapers, LLC D/B/A the Houston Chronicle and Mike Hixenbaugh v. Dr. O. Howard Frazier

CourtCourt of Appeals of Texas
DecidedJanuary 23, 2020
Docket01-19-00009-CV
StatusPublished

This text of Pro Publica, Inc. and Charles Ornstein, Hearst Newspapers, LLC D/B/A the Houston Chronicle and Mike Hixenbaugh v. Dr. O. Howard Frazier (Pro Publica, Inc. and Charles Ornstein, Hearst Newspapers, LLC D/B/A the Houston Chronicle and Mike Hixenbaugh v. Dr. O. Howard Frazier) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pro Publica, Inc. and Charles Ornstein, Hearst Newspapers, LLC D/B/A the Houston Chronicle and Mike Hixenbaugh v. Dr. O. Howard Frazier, (Tex. Ct. App. 2020).

Opinion

Opinion issued January 23, 2020

In The

Court of Appeals For The

First District of Texas ———————————— NO. 01-19-0009-CV ——————————— PROPUBLICA, INC.; HEARST NEWSPAPERS, LLC D/B/A THE HOUSTON CHRONICLE, CHARLES ORNSTEIN, AND MICHAEL HIXENBAUGH, Appellants V. DR. O. HOWARD “BUD” FRAZIER, Appellee

On Appeal from the 234th District Court Harris County, Texas Trial Court Case No. 2018-45639

MEMORANDUM OPINION

Dr. O. Howard “Bud” Frazier sued ProPublica, Inc., Hearst Newspapers, LLC

doing business as The Houston Chronicle, Charles Ornstein, and Michael

Hixenbaugh [collectively, “ProPublica”], for defamation and intentional infliction of emotional distress [“IIED”] in relation to a news story published about him on

ProPublica’s website and in The Houston Chronicle. ProPublica moved to dismiss

under the Texas Citizens Participation Act [“TCPA”]1, and the trial court denied its

motion. Because the trial court failed to follow the proper procedures in TCPA

cases, we reverse the trial court’s order and remand for further proceedings.

BACKGROUND

Dr. O. Howard “Bud” Frazier is one of the world’s leading heart transplant

surgeons and is one of the medical researchers responsible for the development of

the Left Ventricular Assist Device [“LVAD”], a device implanted in patients that

pumps blood through the heart when the heart can no longer do so on its own.

Frazier is the Director of Cardiovascular Surgery Research at Texas Heart Institute

[“THI”], which is affiliated with, and housed and supported by, St. Luke’s Episcopal

Health System.

1 See TEX. CIV. PRAC. & REM. CODE §§27.001–27.011. The Texas Legislature amended certain provisions of the TCPA in 2019. Act of May 17, 2019, 86th Leg., R.S., ch. 378, §§ 1–9, § 12, sec. 27.001, 27.003, 27.005–.007, 27.0075, 27.009–.010 (to be codified at TEX. CIV. PRAC. & REM. §§ 27.001, 27.003, 27.005–.007, 27.0075, 27.009–.010). The amendments became effective September 1, 2019. Id. at § 11. Because suit was filed before the effective date of the amendments, this case is governed by the statute as it existed before the amendments. See id. All our citations and analyses are to the TCPA as it existed prior to September 1, 2019.

2 The Article

On May 24, 2018, ProPublica published an article about Frazier on its website;

the identical article appeared on the Houston Chronicle website on the same date.

On Sunday, May 27, 2018, a print version of the article appeared in the Houston

Chronicle. The article contained a quote in the headline: “Things . . . I just couldn’t

imagine,” followed by the title: “A PIONEERING SURGEON’S HIDDEN

HISTORY OF RESEARCH VIOLATIONS, CONFLICTS OF INTEREST AND

POOR OUTCOMES.”

The article recognized Frazier’s status as a pioneer in the field of mechanical

heart pumps, but also focused on:

(a) findings of research protocol violations that led St. Luke’s/THI to voluntarily report the violations to the federal Office for Human Research Protections (“OHRP”), pledging several reforms, and repaying millions of dollars to the government;

(b) allegations contained in a prior federal lawsuit filed against St. Luke’s/THI and Frazier;

(c) assertions from several of Frazier’s colleagues about his conduct regarding the experimental LVAD research and reporting of its results;

(d) Frazier’s failure to disclose conflicts of interest in medical journals; and

(e) the high rate of mortality among Frazier’s patients, as reflected in official Medicare statistics.

3 The online versions of the article contain links to many of its authors’ sources.

Some of those sources include:

(1) “The Self-Reporting Letter”—a July 2008 letter from St. Luke’s/THI to OHRP, in which it disclosed that it found “instances on ongoing research noncompliance in connection with” the HeartMate II Study. Specifically, the hospital reported that patients participated in Frazier’s HeartMate II Study even though they did not meet the qualifications for participation. St. Luke’s/THI agreed to repay millions of dollars that it had received in federal funding, to audit all then-current studies in which Frazier was the Principal Investigator, and to outsource their Institutional Review Board (“IRB”).

(2) “The Board Summary”—a document prepared by St. Luke’s executives and presented to its Board of Directors, which was also described in the Self-Reporting Letter. The Board Summary found “ongoing research noncompliance” in connections with the protocols governing the HeartMate II Study. The Board Summary recommended repaying millions to the Centers for Medicare and Medicaid Services because of protocol violations in the HeartMate II Study “for claims associated with the use of the investigations devices in these patients. The Board review also references a Legal Compliance Review conducted by the Anson Group that focused on the HeartMate II study and its protocols. Finally, the Board Summary included information submitted by Dr. James Young, who was retained to assess the transplant program led by Frazier. In the Board Summary, Young characterized the program as “an aggressive program that pushes the limits.”

(3) “The Federal Qui Tam Lawsuit”—a lawsuit filed by St. Luke’s employee, Joyce Riley, against St. Luke’s. In the lawsuit, Riley alleged that an unlicensed physician, Dr. Branislav Radovanevic (“Brano”), illegally treated heart failure patients at St. Luke’s/THI. The article quoted from Riley’s pleadings: “Dr. Frazier knew of, directed, and personally participated in the fraudulent conduct and false claims described herein.” The Article then summarized portions of Frazier’s deposition in the lawsuit regarding Brano’s participation in treating Frazier’s patients.

4 (4) “Statements by Frazier’s Former Colleagues”—Dr. Frank Smart, a THI transplant cardiologist from 2003-2006, stated that Frazier implanted heart pumps in some patients that were not sick enough to justify the implant and that it was not the right thing to do. He also reported that there were instances in which, once a patient received a pump, Frazier would then turn down donor hearts for those patients. Smart also reported “hiding” patients from Frazier so that he would not recommend experimental heart pumps to them. Dr. Billy Cohn, a THI heart surgeon reported that Frazier did not want to publish their findings that a quarter of the initial 71 patients implanted with the heart pump had suffered strokes. Cohn said that Frazier didn’t want to “freak people out” with research showing a high rate of serious complications. The Article says that the “initial stroke findings were never published in a formal study,” but acknowledged that they were included in short abstracts at presentations.

(5) “Evidence Regarding Failure to Disclose Conflicts”—the Article discussed research the reporters had obtained showing that Frazier disclosed conflicts of interest in only 10% of his papers. When one journal was contacted, its editor contacted Frazier for a response. The editors reported back that Frazier had agreed to submit revised disclosure forms, which he did. And, the Board Summary had noted that he had failed to accurately complete a conflict of interest form and that the hospital had addressed the issue with him, but “Dr. Frazier still doesn’t understand.”

(6) “Medicare Data Regarding Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

KTRK TELEVISION v. Felder
950 S.W.2d 100 (Court of Appeals of Texas, 1997)
Dean v. Lafayette Place (Section One) Council of Co-Owners, Inc.
999 S.W.2d 814 (Court of Appeals of Texas, 1999)
Bill Youngkin v. Billy G. Hines, Jr.
524 S.W.3d 278 (Court of Appeals of Texas, 2016)
Tervita, LLC v. Casey Sutterfield
482 S.W.3d 280 (Court of Appeals of Texas, 2015)
Newspaper Holdings, Inc. v. Crazy Hotel Assisted Living, Ltd.
416 S.W.3d 71 (Court of Appeals of Texas, 2013)
In re Lipsky
460 S.W.3d 579 (Texas Supreme Court, 2015)
D Magazine Partners, L.P. v. Rosenthal
529 S.W.3d 429 (Texas Supreme Court, 2017)
Van Der Linden v. Khan
535 S.W.3d 179 (Court of Appeals of Texas, 2017)
Hearst Newspapers, LLC v. Status Lounge Inc.
541 S.W.3d 881 (Court of Appeals of Texas, 2017)
Youngkin v. Hines
546 S.W.3d 675 (Texas Supreme Court, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Pro Publica, Inc. and Charles Ornstein, Hearst Newspapers, LLC D/B/A the Houston Chronicle and Mike Hixenbaugh v. Dr. O. Howard Frazier, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pro-publica-inc-and-charles-ornstein-hearst-newspapers-llc-dba-the-texapp-2020.